Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation Enteritis

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

Chronic Radiation Induced Intestinal InjuryChronic Radiation Enteritis

Interventions

BIOLOGICAL

UCB-MNCs

UCB-MNCs will be administered via intravenous infusion three times, once per week, with a dose of 3×10⁸ cells per infusion.

Trial Locations (1)

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors

lead

Zhejiang Cancer Hospital

OTHER